Intermittent fasting has moved well beyond wellness trends and social-media challenges. It is now the subject of hundreds of clinical trials, and researchers are asking a much better question than “Does fasting work?”
They are asking when it works, why it works, whether it works better than other reasonable eating strategies, and who should be careful with it.
That distinction matters for diabetes.
A major 2026 review in The Lancet Diabetes & Endocrinology argued that the evidence around intermittent fasting has matured enough for it to be considered among evidence-based lifestyle options for type 2 diabetes. The authors pointed to more than 225 fasting trials overall, including nearly 40 involving diabetes or prediabetes, and summarized evidence of improvements in HbA1c, glucose, and body weight in some settings. At the same time, they emphasized that fasting is generally comparable to continuous calorie restriction rather than clearly superior to it. Read the 2026 Lancet review.
The American Diabetes Association's 2026 Standards of Care now devote substantial attention to nonreligious fasting and time-restricted eating. The ADA describes these approaches as potentially useful practical strategies for some people with diabetes, while also stressing that healthy eating principles still apply and that people using insulin or medications that stimulate insulin release need medical monitoring.
So the scientific conversation has changed.
The question is no longer whether intermittent fasting is "real." The evidence suggests that it can be useful.
The more important question is whether the fasting itself is doing something special—or whether fasting mainly helps some people eat less, lose weight, and follow a simpler routine.
The short version
If you only remember five things from this article, make them these:
- Intermittent fasting can improve weight and glucose outcomes for some people with type 2 diabetes or prediabetes.
- It is usually not dramatically better than a well-designed calorie-restricted or healthy eating plan.
- A shorter eating window may work partly because it reduces opportunities to eat—not necessarily because fasting creates a unique metabolic advantage.
- Meal timing may have independent biological effects, particularly when eating is shifted earlier in the day, but the clinical evidence is not consistent enough to declare an "ideal" window.
- Fasting can change medication and hypoglycemia risk. It should not be treated as a harmless experiment for everyone.
That is a less exciting message than "16:8 fixes your metabolism."
It is also a much more useful one.
First: "intermittent fasting" is not one diet
One reason fasting discussions become confusing is that very different eating patterns are often given the same label.
An international consensus on fasting terminology was published in 2024 specifically because research groups were using overlapping terms in different ways. The ADA also separates several common forms of intermittent fasting.
Time-restricted eating (TRE) limits food intake to a daily window. A person might eat within 12 hours, 10 hours, 8 hours, or another defined period.
The 5:2 approach typically involves eating normally on five days of the week and substantially reducing energy intake on two days.
Alternate-day fasting alternates usual-intake days with fasting or very-low-calorie days.
These approaches are not metabolically or behaviorally identical. A study of an early 8-hour eating window is not automatically evidence for alternate-day fasting. A 5:2 trial does not prove that skipping breakfast every day will have the same effect.
That is why the details of each study matter.
If you want a more practical framework for what goes on the plate during the eating window, our free Mindful Plate guide focuses on balanced meals without turning food into a math problem.
Why 2026 changed the conversation
The strongest argument for intermittent fasting in 2026 is not that one dramatic new study proved it works.
It is that the evidence base has become large enough to see where fasting does and does not stand out.
The 2026 Lancet review concluded that several forms of intermittent fasting can reduce HbA1c, fasting glucose, 24-hour glucose, and body weight in adults with type 2 diabetes compared with usual eating patterns. The authors argue that this evidence is mature enough for fasting to be incorporated more explicitly into clinical practice guidelines. Read the review.
But the comparison group matters enormously.
A 2026 meta-analysis that included 14 studies and 899 participants found that intermittent fasting performed better than unrestricted eating for several outcomes. When intermittent fasting was compared with continuous energy restriction, however, the differences were much smaller and the approaches were broadly similar for outcomes including HbA1c, body weight, and lipids.
That distinction is the theme of this entire article:
Better than unrestricted eating does not necessarily mean better than another good dietary strategy.
A large 2026 trial found a practical option—not a metabolic miracle
A June 2026 randomized clinical trial provides a useful example of why headlines need context.
Researchers enrolled 247 adults at elevated risk of type 2 diabetes and compared a self-selected 9-hour daily eating window with individualized dietetic guidance. Participants in the fasting group finished eating by 7 p.m. The trial was published in Diabetologia.
At four months, time-restricted eating met the study's definition of non-inferiority to individualized dietetic guidance for HbA1c. In other words, it was not meaningfully worse within the prespecified statistical margin.
But it was not superior.
More importantly, the absolute HbA1c changes in both groups were small and were not considered clinically meaningful. At 12 months, the study could no longer conclude that TRE was non-inferior using the prespecified margin.
That does not make the trial a failure.
The researchers noted that TRE may still offer a pragmatic short-term option for people who prefer a simple time-based structure or who have limited access to dietetic services. Self-reported adherence was actually higher in the TRE group.
The lesson is not "fasting failed."
The lesson is that a simpler schedule can be useful without being biologically superior.
For people looking for a gentle way to test healthier routines rather than adopt an aggressive diet, our free 7-Day Prevention Reset uses small changes in meals, movement, sleep, drinks, and planning instead of a rigid fasting prescription.
HbA1c is important—but it does not show the whole day
HbA1c is useful because it gives a longer-term picture of average blood glucose.
But averages can hide very different daily patterns.
Two people—or two diets—can produce similar average glucose while differing in how often glucose rises too high, drops too low, or swings between the two.
That is where continuous glucose monitoring (CGM) becomes particularly interesting.
In August 2026, researchers published a randomized crossover study of 51 adults with type 2 diabetes comparing continuous calorie restriction with calorie-matched time-restricted intermittent fasting. Participants were drug-naive or taking metformin, had relatively recent type 2 diabetes, and used CGM so researchers could examine glucose patterns throughout the day. Read the Deshmane et al. study.
The result favored continuous calorie restriction for glucose stability:
- Time in range: 92.4% with continuous calorie restriction vs. 81.4% with time-restricted fasting
- Time above range: 4.6% vs. 10.9%
- Time below range: 2.9% vs. 7.7%
This is an important study, but it should not be used to declare fasting "bad."
It was relatively small, involved a specific type 2 diabetes population, and tested a particular fasting protocol. One trial should not erase the rest of the literature.
What it does show is that glucose stability cannot be assumed simply because a diet contains a fasting period.
If you are interested in how CGM data should—and should not—be interpreted, our recent guide to over-the-counter continuous glucose monitoring makes a related point: glucose trends are information, but they still need context.
Does fasting work because of the fasting—or because people eat less?
This may be the most important scientific question in the entire field.
When people shorten the number of hours available for eating, they often reduce their total energy intake without deliberately counting calories.
In a six-month randomized trial of 75 adults with type 2 diabetes, an 8-hour TRE group reduced energy intake by about 313 kcal per day on average, compared with about 197 kcal per day in the calorie-restriction group. TRE produced more weight loss versus the control group, but HbA1c improved similarly with TRE and daily calorie restriction. Read the JAMA Network Open trial.
That raises a reasonable possibility: perhaps the eating window works partly because it makes calorie reduction easier for some people.
A particularly informative 2024 controlled feeding study tried to isolate timing from calories. Forty-one adults with obesity and prediabetes or diet-controlled diabetes received diets with the same calorie and nutrient content. One group used a 10-hour early eating window; the other used a usual eating pattern.
When calories were held stable, the time-restricted group did not lose more weight and did not show better glucose homeostasis than the comparison group.
That finding does not prove that meal timing has no independent biology.
It does, however, make it much harder to claim that the clock alone explains most of fasting's benefits.
Does eating earlier matter?
There is a good biological reason scientists are interested in when people eat.
Glucose tolerance, insulin action, hormones, sleep-wake cycles, and many other metabolic processes follow circadian rhythms. The ADA's 2026 Standards note that glucose tolerance tends to be better during daylight hours and describe chrononutrition as a promising—but still evolving—area of research.
Some controlled studies support the idea that earlier eating may matter.
A small but influential 2018 controlled feeding study in men with prediabetes found that early time-restricted feeding improved insulin sensitivity and several cardiometabolic measures even without intentional weight loss.
A 2023 Nature Medicine randomized trial of 209 adults at increased risk of type 2 diabetes also found that an intermittent fasting strategy combined with early time-restricted eating improved post-meal glucose tolerance more than daily calorie restriction at six months. But that advantage was no longer present at the 18-month follow-up.
Other studies are less convincing.
A 2024 Diabetologia trial compared early time-restricted carbohydrate intake with a Mediterranean-style diet matched for energy restriction and macronutrients in people with type 2 diabetes. Both approaches improved outcomes, without a clear metabolic victory for the timing-based strategy.
And a 2022 randomized crossover trial found that three weeks of daytime time-restricted eating improved 24-hour glucose levels and time in a normal glucose range in adults with type 2 diabetes, but did not improve insulin sensitivity.
Put together, the evidence supports a measured conclusion:
Earlier eating is biologically plausible and sometimes beneficial, but we do not yet have strong enough evidence to say that everyone with diabetes should eat within one specific clock window.
Is 16:8 actually better than eating a healthier diet?
There is no convincing evidence that 16:8 itself is a uniquely optimal ratio.
It is popular because an 8-hour eating window is easy to explain and has been used in many studies. That popularity can make it sound as though science has identified "16:8" as the metabolic sweet spot.
It has not.
The ADA describes time-restricted eating windows across a broader range, and research has tested multiple schedules. More importantly, the most consistent message across the evidence is that diet quality, total energy intake, adherence, weight change when appropriate, and individual medical needs still matter.
That is why a person can follow a technically perfect fasting window and still have a poor-quality diet.
It is also why someone following a balanced Mediterranean-style eating pattern without fasting may do very well.
The ADA Standards of Care continue to emphasize individualized meal plans and nutrient-dense eating patterns, including vegetables, fruits, legumes, whole grains, nuts, seeds, lean proteins, and other minimally processed foods.
The clock does not cancel the plate.
What happens when people stop fasting?
Short-term results are only part of the story.
A 2025 systematic review and meta-analysis of randomized trials in type 2 diabetes found significant short-term improvements in HbA1c, fasting glucose, and body weight compared with control interventions. Longer-term effects were more similar between intermittent fasting and comparison diets, and benefits did not reliably persist after fasting was discontinued.
That is exactly what we should expect from most lifestyle interventions.
A strategy cannot help much after it becomes a routine someone cannot or does not want to follow.
Sustainability is therefore not a soft, secondary outcome.
Sustainability is part of efficacy.
For some people, "I only need to think about when I eat" may feel much easier than tracking calories.
For someone else, a strict window may interfere with work, family meals, exercise, medication schedules, cultural traditions, sleep, or a healthy relationship with food.
Neither response is a character flaw. It is information about fit.
Medication changes the safety equation
For people who do not take glucose-lowering medications, skipping or delaying a meal may simply cause hunger or inconvenience.
For someone using insulin or a medication that can cause hypoglycemia, the same change can alter the balance between food, medication, and blood glucose.
The ADA specifically advises medical monitoring during fasting for people taking insulin or insulin secretagogues such as sulfonylureas. The 2026 Lancet review likewise emphasizes medication adjustment as a central part of fasting safety.
A small randomized trial called INTERFAST-2 showed that intermittent fasting could be feasible in people with insulin-treated type 2 diabetes. But the context matters: participants received dietary counseling, continuous glucose monitoring, and a structured medication-management approach.
That is not the same as independently deciding to skip meals while keeping a medication plan unchanged.
People using SGLT2 inhibitors also need individualized guidance around situations involving markedly reduced intake, dehydration, illness, or ketosis because of ketoacidosis risk. The safest plan depends on the specific medication, dose, glucose history, kidney function, and clinical situation.
Do not change insulin or diabetes medication doses based on this article or a fasting schedule found online.
Who needs extra caution?
Fasting should not be framed as universally safe or universally unsafe.
It should be framed as an intervention whose risk depends on the person.
Insulin or hypoglycemia-causing medications
Meal timing changes can increase the risk of low blood sugar when insulin or certain medications are active. Medical supervision may be needed before the eating pattern changes.
Type 1 diabetes
The 2026 Lancet review concluded that evidence remains insufficient to recommend intermittent fasting as a general treatment strategy for type 1 diabetes. Fasting can interact with insulin requirements, hypoglycemia, hyperglycemia, and ketone production.
Pregnancy or breastfeeding
These are periods of changing nutritional and metabolic needs. Evidence is not strong enough to recommend intermittent fasting as a routine diabetes strategy during pregnancy, and individualized medical guidance is appropriate during pregnancy or breastfeeding.
Recurrent or severe hypoglycemia
A history of dangerous lows changes the risk-benefit calculation. A diet that increases time without food can be inappropriate without specialist guidance.
Older adults, frailty, or difficulty maintaining nutrition
Restrictive eating can make it harder to maintain adequate energy, protein, micronutrients, and muscle mass. The ADA specifically includes frailty and cognitive status in fasting risk assessment discussions.
History of disordered eating
The ADA recommends screening for disordered eating and notes that rigid meal plans or strict tracking can be contraindicated in people at increased risk of maladaptive eating behaviors.
If a fasting routine increases fear of food, guilt, binge-restrict cycles, compulsive tracking, or anxiety around normal glucose fluctuations, that is not a sign to become "more disciplined."
It is a sign that the strategy may not be a healthy fit.
If someone wants to try fasting, what does a reasonable approach look like?
There is no single fasting prescription that belongs in a general health article.
A safer process starts with questions.
1. What is the goal? Is the person trying to simplify meal planning, reduce late-night eating, support weight management, improve glucose patterns, or solve a problem that may actually require medical evaluation?
2. What medications are involved? Insulin, sulfonylureas, meglitinides, SGLT2 inhibitors, and other therapies may change the safety conversation.
3. Is the plan nutritionally sound? A shorter window does not make low-fiber, highly processed food metabolically ideal. Our Mindful Plate and Free Health Guides library focus on meal quality and practical habits that can be used with or without fasting.
4. Is it sustainable? A plan that works for two weeks but repeatedly collides with work, sleep, family life, exercise, or mental health is probably not the best long-term plan.
5. What will be monitored? Depending on the person, useful outcomes might include glucose patterns, hypoglycemia, body weight when relevant, energy, sleep, hunger, medication needs, lab results, and whether the routine is becoming easier or harder to live with.
6. What would make the person stop and call their healthcare team? Repeated low glucose, significant hyperglycemia, ketones, dizziness, fainting, dehydration, worsening weakness, medication problems, or an unhealthy relationship with food deserve attention.
The goal is not to "win" at fasting.
The goal is to find a safe eating pattern that supports health and can actually be lived.
Do not let meal timing crowd out the other things that matter
One of the risks of a popular diet framework is that it becomes the only behavior people pay attention to.
Blood sugar and long-term metabolic health are influenced by far more than an eating window.
Regular movement can improve glucose use and insulin sensitivity. Even walking is meaningful; our guide to walking with diabetes focuses on one of the most accessible forms of activity.
Sleep and stress influence appetite, hormones, decision-making, and glucose patterns. Our educational resource library includes plain-language guides on sleep, stress, insulin resistance, movement, and working with your healthcare team.
And metabolic health matters beyond a single glucose value. Our free Blood Sugar & Brain Health guide explores how metabolic, cardiovascular, and daily-life factors can intersect with long-term cognitive health without suggesting that dementia is inevitable.
Fasting can be one tool.
It should not become the toolbox.
So: helpful tool, overhyped trend, or both?
Both.
Intermittent fasting has earned a place in serious diabetes research. The evidence is now too substantial to dismiss it as a fad.
For some people—especially those with type 2 diabetes or prediabetes who can fast safely—a time-based eating structure may make it easier to reduce energy intake, lose weight when appropriate, and improve glucose-related outcomes.
But the evidence does not support the idea that fasting is metabolic magic.
When intermittent fasting is compared with another well-designed dietary strategy instead of unrestricted eating, the advantage often becomes smaller or disappears. Controlled feeding research suggests that calorie reduction explains at least part of the effect. Circadian timing may add benefits in some settings, but the best schedule is still unsettled. And the newest CGM research reminds us that fasting does not automatically produce more stable glucose.
The most useful 2026 conclusion is therefore not:
Everyone should fast.
And it is not:
Fasting does nothing.
It is this:
Intermittent fasting is one evidence-based tool that may work well for some people. It deserves the same questions we should ask of any diabetes strategy: Is it safe? Is it nutritionally sound? Does it improve meaningful outcomes? And can the person actually sustain it?
If the answer is yes, the clock may be useful.
But the clock is not the whole story.
Continue building the habits that matter
Want practical support without committing to a rigid diet?
- Explore all of our free Mindful Diabetes health guides.
- Start with The Mindful Plate for flexible blood sugar-conscious meals.
- Try the 7-Day Prevention Reset for a gentle week of small habit experiments.
- Read Blood Sugar & Brain Health for the bigger metabolic-health picture.
- Learn about Memovela, our wellness tracker for building repeatable routines around meals, movement, sleep, hydration, and personal goals.
Educational information only. This article does not diagnose, treat, or prescribe a fasting plan. Individual nutrition and medication decisions should be made with qualified healthcare professionals.
Scientific sources and further reading
- Varady KA, Chow LS, Peterson CM. Intermittent fasting to treat diabetes: time to update clinical practice guidelines. Lancet Diabetes Endocrinol. 2026. doi:10.1016/S2213-8587(26)00119-1.
- American Diabetes Association Professional Practice Committee. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
- Koppold DA, et al. International consensus on fasting terminology. Cell Metab. 2024. doi:10.1016/j.cmet.2024.06.013.
- Parr EB, et al. Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes. Diabetologia. 2026. doi:10.1007/s00125-026-06762-x.
- Chen et al. Efficacy of intermittent fasting on blood glucose and weight in type 2 diabetes and prediabetes. 2026.
- Deshmane AR, et al. Effects of continuous calorie restriction versus time-restricted intermittent fasting on glycemic variability in individuals with type 2 diabetes. Diabetol Metab Syndr. 2026. doi:10.1186/s13098-026-02275-0.
- Liu F, et al. The metabolic effects of intermittent fasting in patients with type 2 diabetes exist in the short term but disappear after its discontinuation. Nutr Res. 2025. doi:10.1016/j.nutres.2025.04.008.
- Pavlou V, et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes. JAMA Netw Open. 2023. doi:10.1001/jamanetworkopen.2023.39337.
- Maruthur NM, et al. Effect of Isocaloric, Time-Restricted Eating on Body Weight in Adults With Obesity. Ann Intern Med. 2024. doi:10.7326/M23-3132.
- Tricò D, et al. Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes. Diabetologia. 2024. doi:10.1007/s00125-023-06045-9.
- Sutton EF, et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018. doi:10.1016/j.cmet.2018.04.010.
- Teong XT, et al. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes. Nat Med. 2023. doi:10.1038/s41591-023-02287-7.
- Andriessen C, et al. Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity. Diabetologia. 2022. doi:10.1007/s00125-022-05752-z.
- Obermayer A, et al. Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2). Diabetes Care. 2023. doi:10.2337/dc22-1622.